---
figid: PMC9657131__cells-11-03445-g001
figtitle: 'Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems
  to Nanozymes'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9657131
filename: cells-11-03445-g001.jpg
figlink: /pmc/articles/PMC9657131/figure/cells-11-03445-f001/
number: F1
caption: 'Neurophysiology of motor control (left) and proteostasis regulation (right)
  in healthy midbrain substantia nigra pars compacta dopaminergic neurons. In regular
  motor control, DA (synthesized from L-tyrosine) is encapsulated in synaptic vesicles
  by VMAT2. and then released to excite DA receptors D1R and D2R, thereby triggering
  the direct and indirect pathways of motor regulation, respectively. DA can spillover
  if not reuptaken by the neuron through the DAT. Free DA in the cytosol and the extracellular
  matrix can be oxidized by MAO-A into neurotoxic by-products. On the other hand,
  α-syn regulates the docking, fusion, and release of DA from synaptic vesicles are
  regulated. When the protein is misfolded, dopaminergic neurons eliminate it through
  the UPP or the ALP pathways. DA: dopamine; L-DOPA: levodopa; VMAT2: vesicular monoamine
  transporter 2; MAO-A: monoamine oxidase A; D1R: dopamine 1 receptor; D2R: dopamine
  2 receptor; DAT: dopamine transporter; α-syn: alpha-synuclein; NAC: non-amyloidogenic
  component; Ub: ubiquitin; UPP: ubiquitin-proteasome pathway; ALP: autophagy-lysosomal
  pathway. Figure made in BioRender.com.'
papertitle: 'Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems
  to Nanozymes.'
reftext: Francisco J. Padilla-Godínez, et al. Cells. 2022 Nov;11(21):3445.
year: '2022'
doi: 10.3390/cells11213445
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: nanomedicine | Parkinson’s disease | controlled drug delivery | nanocarrier
  | nanozyme
automl_pathway: 0.9306061
figid_alias: PMC9657131__F1
figtype: Figure
redirect_from: /figures/PMC9657131__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9657131__cells-11-03445-g001.html
  '@type': Dataset
  description: 'Neurophysiology of motor control (left) and proteostasis regulation
    (right) in healthy midbrain substantia nigra pars compacta dopaminergic neurons.
    In regular motor control, DA (synthesized from L-tyrosine) is encapsulated in
    synaptic vesicles by VMAT2. and then released to excite DA receptors D1R and D2R,
    thereby triggering the direct and indirect pathways of motor regulation, respectively.
    DA can spillover if not reuptaken by the neuron through the DAT. Free DA in the
    cytosol and the extracellular matrix can be oxidized by MAO-A into neurotoxic
    by-products. On the other hand, α-syn regulates the docking, fusion, and release
    of DA from synaptic vesicles are regulated. When the protein is misfolded, dopaminergic
    neurons eliminate it through the UPP or the ALP pathways. DA: dopamine; L-DOPA:
    levodopa; VMAT2: vesicular monoamine transporter 2; MAO-A: monoamine oxidase A;
    D1R: dopamine 1 receptor; D2R: dopamine 2 receptor; DAT: dopamine transporter;
    α-syn: alpha-synuclein; NAC: non-amyloidogenic component; Ub: ubiquitin; UPP:
    ubiquitin-proteasome pathway; ALP: autophagy-lysosomal pathway. Figure made in
    BioRender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - da
  - nAChRalpha2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Dop2R
  - Dop1R2
  - ap
  - Poxn
  - DAT
  - speck
  - nac
  - Nacalpha
  - daw
  - Ablp
  - SLC18A2
  - MAOA
  - DRD2
  - DRD1
  - SLC6A3
  - XK
  - NLRP1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - UPP1
  - MRFAP1L2
  - UPRT
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - L-Tyrosine
  - L-DOPA
  - 'N'
  - NAC C
  - toxicity
  - ALP
---
